Tickerover
Consumer Defensive

CVSA Stock Analysis

Covista Inc. · current price $134.63 (-4.28% today)

Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
★★★★★
Top Tier
📊

The six-pillar scorecard

Momentum
67
Drifting higher
price trend
Growth
25
Barely growing
sales & profit growth
Quality
96
High quality
profitability & balance sheet
Valuation
65
Fairly priced
is the price fair?
Sentiment
40
Mixed views
analyst & crowd mood
Risk
73
Low risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
FundamentalsFundamentals: 7878Earnings qualityEarnings quality: 8989RSI zoneRSI zone: 100100Trend strengthTrend strength: 100100Analyst consensusAnalyst consensus: 7070Relative strengthRelative strength: 65651-month momentum1-month momentum: 6262
Margin profileWhat survives each step down the income statement.
GrossGross: 57.3%57.3%OperatingOperating: 19.3%19.3%NetNet: 12.9%12.9%Free cash flowFree cash flow: 20.1%20.1%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +10.4% vs estimate+10%2026-062026-03: +14.9% vs estimate+15%2026-032025-12: +11.1% vs estimate+11%2025-122025-09: +10.9% vs estimate+11%2025-09
👁

Hype Check

Reading CVSA’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading CVSA’s filings…

📣

Latest earnings

LAST EARNINGS Covista Inc. (CVSA)

Latest earnings

EPS
$1.75 vs $1.58 est · +10.9% vs estimate BEAT
Revenue
$501.4M · +8.5% YoY
Stock reaction (1M)
+6.3%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
18.0×
Forward P/E
13.4×
PEG
1.04
Price / Sales
2.3×
Price / Book
3.2×
EV / EBITDA
11.4×
Analyst target
$159.50
Target range
$140.00 – $175.00
Implied upside
+18.5%
🩺

Financial health

Gross margin
57.3%
Operating margin
19.3%
Net margin
12.9%
FCF margin
20.1%
Return on equity
18.6%
Debt / equity
0.63
Revenue growth YoY
+9.7%
EPS growth YoY
+43.2%
📈

Technicals

$86.9752-week range$156.26
RSI (14)
54
50-day MA
$127.13
200-day MA
$113.73
ATR (14)
5.03
Beta
0.62
1-month return
+6.3%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$1.75$1.58+10.9%Beat
2025-12-31$2.43$2.19+11.1%Beat
2026-03-31$1.98$1.72+14.9%Beat
2026-06-30$2.09$1.89+10.4%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.07%
Beta
0.62
📰

Latest news on CVSA

🔗

Similar stocks in Consumer Defensive

Frequently asked

What is CVSA's Quant Score?

Covista Inc. (CVSA) currently has a TickerMover Quant Score of 77/100, rated ★★★★★ Top Tier. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Covista Inc. (CVSA) a buy?

TickerMover does not give buy or sell recommendations. CVSA scores 77/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is CVSA's score updated?

CVSA's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for CVSA →